Table 4.
Proportion of Women with Major Osteoporotic Fractures during 10-year Follow-up who are Identified for Bone Mineral Density Testing under the USPSTF and Canadian Strategies*
Strategy | Age Group | Total n | Identified for screening, n (%) | MOF Events, n (%) | Sensitivity (95% CI) | Specificity (95% CI) | Positive Predictive Value (95% CI) |
---|---|---|---|---|---|---|---|
All Participants | 115257 | 62546 (54%) | 14105 (12%) | 72.5 (71.8, 73.3) | 48.3 (48.0, 48.6) | 16.4 (16.1, 16.6) | |
75–79 | 5907 | 5907 (100%) | 1732 (29%) | 100.0 (–) | 0.0 (–) | 29.3 (28.2, 30.5) | |
All Participants | 115257 | 82599 (72%) | 14105 (12%) | 82.9 (82.2, 83.5) | 29.9 (29.6, 30.2) | 14.1 (13.9, 14.4) | |
75–79 | 5907 | 5907 (100%) | 1732 (29%) | 100.0 (–) | 0.0 (–) | 29.3 (28.2, 30.5) |
Major osteoporotic fractures (MOF) are defined as adjudicated hip fracture or self-report fracture of lower arm/wrist, spine/back, or upper arm/shoulder. USPSTF denotes United States Preventive Services Task Force